In the largest prospective study to date examining the use of chimeric antigen receptor (CAR)-T therapy in a community ...

FDA confirms that SciSparc’s study may proceedonly a month after application submission TEL AVIV, Israel, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ...

Medical marijuana is losing attention in the cannabis industry, raising concerns about its future and impact on patients. Policy changes may further sideline it.

The Mandi bypass section of the Kiratpur-Manali four-lane road project was opened to traffic trials in the district on Monday. The event was attended by Deputy Commissioner Apoorv Devgan, National ...

Hulk Hogan was the biggest star Vince McMahon ever created, but Hogan eventually left WWE for WCW. How did that affect their ...

Cheong points to the broad spectrum of patient demographics in the APAC region for creating substantial opportunities for clinical trial sponsors who are keen to meet enrolment targets at an expedited ...

MediciNova holds Orphan Drug Designation for MN-166 (ibudilast) in ALS by U.S. FDA and EU EMA. MN-166 (ibudilast) has received Fast Track Designation by FDA for treatment of ALS. In addition, MN-166 ...

Eli Lilly's Ebglyss gains FDA approval for atopic dermatitis treatment, poised to rival Dupixent with strong performance in ...

While previous trials have led to questions surrounding the potential benefits of valve interventions in mitral or tricuspid regurgitation, a pair of trials presented recently demonstrate their ...

InCarda Therapeutics, Inc.: Today, InCarda, a privately held biopharmaceutical company developing an inhaled flecainide acetate inhalation solution (FlecIH-103) for the acute conversion of paroxysmal ...

Johnson & Johnson linked Carvykti to a 45% reduction in risk of death and Darzalex to a 61% improvement in minimal residual ...

While AI's role in clinical trial design and real-time monitoring is well-known, it also brings unprecedented potential in ...